Weekly Exenatide Therapy: A Real-World Comparison of Incretin Therapies

Background: Traditional diabetes therapies have been associated with weight gain, hypoglycemia, and/or high secondary failure rates. Glucagon-like peptide-1 (GLP-1) analog use is associated with a minimal risk of hypoglycemia, a persistent average weight loss of 2 to 3 kg, and sustained efficacy eve...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Pharm Technol
Hoofdauteurs: Micale, Sara J., Khatounabadi, Shahabodin, Kane, Michael P., Busch, Robert S., Bakst, Gary, Abelseth, Jill M., Hamilton, Robert A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SAGE Publications 2014
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5990137/
https://ncbi.nlm.nih.gov/pubmed/34860898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122513518189
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items